DK1187928T3 - Viruslignende partikler, fremstilling og anvendelse ved screening samt ved funktionel genomics - Google Patents
Viruslignende partikler, fremstilling og anvendelse ved screening samt ved funktionel genomicsInfo
- Publication number
- DK1187928T3 DK1187928T3 DK00949236T DK00949236T DK1187928T3 DK 1187928 T3 DK1187928 T3 DK 1187928T3 DK 00949236 T DK00949236 T DK 00949236T DK 00949236 T DK00949236 T DK 00949236T DK 1187928 T3 DK1187928 T3 DK 1187928T3
- Authority
- DK
- Denmark
- Prior art keywords
- particles
- virus
- preparation
- screening
- functional genomics
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4722—G-proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/586—Liposomes, microcapsules or cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/73—Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Communicable Diseases (AREA)
- General Physics & Mathematics (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14126899P | 1999-06-30 | 1999-06-30 | |
EP99112451 | 1999-06-30 | ||
EP00106109 | 2000-03-21 | ||
EP00110363 | 2000-05-15 | ||
PCT/EP2000/006144 WO2001002551A2 (en) | 1999-06-30 | 2000-06-30 | Virus like particles, preparation and use in screening and functional genomics |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1187928T3 true DK1187928T3 (da) | 2007-10-08 |
Family
ID=56290037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00949236T DK1187928T3 (da) | 1999-06-30 | 2000-06-30 | Viruslignende partikler, fremstilling og anvendelse ved screening samt ved funktionel genomics |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1187928B1 (da) |
JP (1) | JP2003504014A (da) |
AT (1) | ATE362990T1 (da) |
AU (1) | AU6267000A (da) |
DE (1) | DE60034947T2 (da) |
DK (1) | DK1187928T3 (da) |
WO (1) | WO2001002551A2 (da) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7763258B2 (en) | 1997-05-20 | 2010-07-27 | The Trustees Of The University Of Pennsylvania | Virus-like particles (VLPs) comprising heterologous multiple membrane spanning proteins |
US7476517B2 (en) | 1999-06-30 | 2009-01-13 | Evotec Ag | Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
US20040014033A1 (en) | 1999-06-30 | 2004-01-22 | Evotec Biosystems Ag, A Corporation Of Germany | Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
US7622437B2 (en) | 2000-11-20 | 2009-11-24 | The Board Of Trustees Of The University Of Illinois | Tissue factor compositions and methods |
EP1345959B1 (en) | 2000-11-20 | 2011-05-25 | The Board Of Trustees Of The University Of Illinois | Membrane scaffold proteins |
US7083958B2 (en) | 2000-11-20 | 2006-08-01 | The Board Of Trustees Of The University Of Illinois | Membrane scaffold proteins |
US7592008B2 (en) | 2000-11-20 | 2009-09-22 | The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois | Membrane scaffold proteins |
EP1219705B1 (en) * | 2000-12-29 | 2007-11-28 | Evotec AG | Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics |
US7070978B2 (en) | 2001-06-20 | 2006-07-04 | Toudai Tlo, Ltd. | Method for expressing and purifying proteins using budded baculovirus |
EP1632778A3 (en) | 2001-07-09 | 2006-03-29 | Euroscreen S.A. | Natural ligand of gpcr chemr23 and uses thereof |
JP2003052370A (ja) * | 2001-08-16 | 2003-02-25 | Sentan Kagaku Gijutsu Incubation Center:Kk | 発芽バキュロウィルスを用いた機能を有する膜型受容体蛋白質の発現法 |
AU2002359332A1 (en) * | 2001-10-30 | 2003-05-12 | Vertex Pharmaceuticals Incorporated | Noe-nmr based methods for the identifycation of compounds which can bind to membrane receptors |
JP2003177131A (ja) * | 2001-12-11 | 2003-06-27 | Olympus Optical Co Ltd | 生物学的な結合親和性を検出する方法 |
EP1463759B8 (en) | 2002-01-07 | 2013-07-10 | Euroscreen S.A. | Ligand for g-protein coupled receptor gpr43 and uses thereof |
CA2490866A1 (en) * | 2002-06-26 | 2004-01-08 | Advanced Bionutrition Corporation | Viruses and virus-like particles for multiple antigen and target display |
JP2004093527A (ja) * | 2002-09-04 | 2004-03-25 | Center For Advanced Science & Technology Incubation Ltd | 蛍光共鳴エネルギー転移を用いた蛋白質の分析方法 |
US8574590B2 (en) | 2003-07-30 | 2013-11-05 | Integral Molecular, Inc. | Lipoparticles comprising proteins, methods of making, and using the same |
EP1773303A2 (en) | 2004-05-25 | 2007-04-18 | Chimeracore, Inc. | Self-assembling nanoparticle drug delivery system |
US8377691B2 (en) * | 2006-01-26 | 2013-02-19 | Integral Molecular, Inc. | Lipoparticles comprising ion channels, methods of making and using the same |
EP2018156B1 (en) | 2006-04-07 | 2010-03-17 | Chimeros, Inc. | Compositions and methods for treating b- cell malignancies |
WO2010120874A2 (en) | 2009-04-14 | 2010-10-21 | Chimeros, Inc. | Chimeric therapeutics, compositions, and methods for using same |
EP2753643A2 (en) | 2011-09-08 | 2014-07-16 | Institut National De La Recherche Agronomique (INRA) | Novel pheromonal receptor of spodoptera littoralis (lepidoptera, noctuidae) and identification of natural ligand of said receptor and uses thereof |
EP2747774A4 (en) | 2011-09-09 | 2015-02-11 | Biomed Realty L P | METHOD AND COMPOSITIONS FOR CONTROLLING VIRUS PROTECTION |
WO2013174999A1 (en) * | 2012-05-24 | 2013-11-28 | Vib Vzw | Virus-like particle based protein-protein interaction |
DK3004157T3 (da) | 2013-05-31 | 2017-12-11 | Chemcom Sa | Olfaktoriske receptorer involveret i perceptionen af sved-carboxylsyrer og anvendelsen deraf |
JP6863897B2 (ja) | 2015-01-09 | 2021-04-21 | アダルタ・リミテッド | Cxcr4結合分子 |
GB201504859D0 (en) | 2015-03-23 | 2015-05-06 | Vib Vzw | Viral particle based small molecule-protein interaction trap |
EP3445397B1 (en) * | 2016-04-22 | 2022-11-09 | Vaccinex, Inc. | Integral membrane protein display on poxvirus extracellular enveloped virions |
ES2943459T3 (es) | 2017-12-05 | 2023-06-13 | Chemcom Sa | Receptor olfativo implicado en la percepción de fragancia de almizcle y el uso del mismo |
JP7491932B2 (ja) | 2018-12-28 | 2024-05-28 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 操作されたb型肝炎コアポリペプチド |
WO2024127321A1 (en) * | 2022-12-14 | 2024-06-20 | Ustav Jr Mart | Engineered virus-like-particles for targeted capture of membrane proteins |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988003563A1 (en) * | 1986-11-01 | 1988-05-19 | Oxford Gene Systems Limited | Fusion proteins and particles |
EP0768377A1 (en) * | 1988-09-02 | 1997-04-16 | Protein Engineering Corporation | Generation and selection of recombinant varied binding proteins |
IL106362A (en) * | 1992-07-16 | 1998-12-06 | Oxford University | A system for launching multiple particle antigens |
GB9223084D0 (en) * | 1992-11-04 | 1992-12-16 | Imp Cancer Res Tech | Compounds to target cells |
GB9304239D0 (en) * | 1993-03-01 | 1993-04-21 | British Bio Technology | Viral particles |
EP0817854A2 (en) * | 1995-03-31 | 1998-01-14 | Wolf, Hans, Prof. Dr. | Antigen presentation system based on retrovirus-like particles |
JPH11511651A (ja) * | 1995-05-10 | 1999-10-12 | イントロヘーネ ベスローテン フェンノートシャップ | 遺伝子治療に特に適した改良型レトロウイルスベクター |
DE19543553B4 (de) * | 1995-11-22 | 2009-04-09 | Deutsches Primatenzentrum Gmbh | VP-Antigene des JC-Virus |
US8349602B1 (en) * | 1996-04-19 | 2013-01-08 | Xenogen Corporation | Biodetectors targeted to specific ligands |
EP0922105B1 (en) * | 1996-07-17 | 2005-12-07 | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Infectious papillomavirus pseudoviral particles |
AUPO434196A0 (en) * | 1996-12-24 | 1997-01-23 | Crown In The Right Of The Queensland Department Of Health, The | An improved therapeutic |
AU7350798A (en) * | 1997-04-29 | 1998-11-24 | Universiteit Utrecht | Corona virus-like particles as tools for vaccination and therapy |
US6451527B1 (en) * | 1997-08-29 | 2002-09-17 | Selective Genetics, Inc. | Methods using genetic package display for selecting internalizing ligands for gene delivery |
US6171591B1 (en) * | 1997-12-08 | 2001-01-09 | Pentamer Pharmaceuticals, Inc. | Recombinant nodavirus compositions and methods |
CA2317816C (en) * | 1998-01-09 | 2009-02-17 | Tvw Telethon Institute For Child Health Research | Peptide detection method |
GB9806666D0 (en) * | 1998-03-27 | 1998-05-27 | Stanley Margaret | Antigen preparation and use |
EP0959135A1 (en) * | 1998-05-20 | 1999-11-24 | Introgene B.V. | Display of viral proteins and targeted delivery to cellular receptor |
EP0960942A3 (en) * | 1998-05-20 | 2000-01-12 | Introgene B.V. | Targeted delivery through a cationic amino acid transporter |
AU753391B2 (en) * | 1998-08-14 | 2002-10-17 | Merck Sharp & Dohme Corp. | Protein delivery system using human papillomavirus virus-like particles |
-
2000
- 2000-06-30 AU AU62670/00A patent/AU6267000A/en not_active Abandoned
- 2000-06-30 JP JP2001508324A patent/JP2003504014A/ja not_active Abandoned
- 2000-06-30 WO PCT/EP2000/006144 patent/WO2001002551A2/en active IP Right Grant
- 2000-06-30 EP EP00949236A patent/EP1187928B1/en not_active Expired - Lifetime
- 2000-06-30 DK DK00949236T patent/DK1187928T3/da active
- 2000-06-30 AT AT00949236T patent/ATE362990T1/de not_active IP Right Cessation
- 2000-06-30 DE DE60034947T patent/DE60034947T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1187928A2 (en) | 2002-03-20 |
AU6267000A (en) | 2001-01-22 |
WO2001002551A2 (en) | 2001-01-11 |
DE60034947T2 (de) | 2008-01-24 |
EP1187928B1 (en) | 2007-05-23 |
JP2003504014A (ja) | 2003-02-04 |
DE60034947D1 (de) | 2007-07-05 |
ATE362990T1 (de) | 2007-06-15 |
WO2001002551A3 (en) | 2001-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1187928T3 (da) | Viruslignende partikler, fremstilling og anvendelse ved screening samt ved funktionel genomics | |
WO2002002783A3 (en) | Expression vectors | |
BR0011499A (pt) | Moléculas de ácido nucléico oriundas de plantas e células de,planta transgênicas de trigo e o seu uso para a produção de amido modificado | |
DE60142614D1 (de) | Inität | |
PT1685243E (pt) | Linhas celulares aviárias imortalizadas para a produção de vírus | |
ATE483970T1 (de) | Zellen zur entdeckung von medikamenten | |
WO2001019405A3 (de) | Magnetische nanoteilchen mit biochemischer wirksamkeit und verfahren zu ihrer herstellung sowie ihre verwendung | |
BR9807502B1 (pt) | compostos orgÂnicos, processo para sua preparaÇço, bem como composiÇço e aplicaÇço dos mesmos. | |
DE69836388D1 (de) | System und verfahren zur zerkleinerung von material | |
AU2002224903A1 (en) | Cosmetic and/or dermopharmaceutical preparations containing native proteins from the plant argania spinosa | |
ID24714A (id) | Turunan tiazolidindion tersubstitusi, proses pembuatannya dan penggunaan bahan farmasinya | |
DE60305438D1 (de) | Lyophilisierte pharmazeutische zusammensetzung von propofol | |
MA26900A1 (fr) | Preparations cosmetiques et/ou pharmaceutiques avec un extrait de la plante argania spinosa. | |
DK1082423T3 (da) | Cyclin E2-gener og -proteiner | |
WO2003020892A3 (en) | Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY | |
WO2000044775A3 (en) | Identification of broadly reactive hla restricted t cell epitopes | |
WO1999063941A3 (en) | Novel hepatitis c virus peptides and uses thereof | |
WO2001066752A3 (en) | Reproduction-specific genes | |
ATE311456T1 (de) | Nucleinsäure-moleküle codierend proteine, die die adhäsion von neisseria-zellen an humane zellen vermitteln | |
DE60037263D1 (de) | Virus-ähnliche Partikel, ihre Herstellung und ihre Verwendung beim pharmazeutischen Screening und funktionelle Genomanwendungen | |
WO1999012945A3 (en) | Hydrophobic glycosylamine derivatives, compositions, and methods for use | |
GB9906018D0 (en) | Expression of DNA or proteins in C.elegans | |
DE69934399D1 (de) | Komplex aus peptid und mhc-peptid auf oberfläche von phagen | |
AU2347501A (en) | Trp-protein-related mtr1 protein and dna sequence coding therefor | |
DE69728447D1 (de) | Veränderte, kleine rna-viren |